TCG CROSSOVER MANAGEMENT, LLC 13F Portfolio
TCG CROSSOVER MANAGEMENT, LLC runs TCG CROSSOVER MANAGEMENT, LLC and currently holds 54 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $4.16B. Their top holdings are ABVX, TNGX, CGON, COGT, IMVT. The top five represent 41.0% of reported portfolio weight. TCG CROSSOVER MANAGEMENT, LLC ranks #26 out of 1000 investors tracked by Alpha Score. In the most recent quarter, TCG CROSSOVER MANAGEMENT, LLC initiated 6 new positions. They trimmed 8 positions. Their current best-performing preview position is RVMD with returns of +92.58%.
Portfolio Value
$4.16B
Alpha Score
255.7
#26 of 1000
Holdings
54
TCG CROSSOVER MANAGEMENT, LLC Current 13F Holdings
Reported holdings from TCG CROSSOVER MANAGEMENT, LLC's latest SEC 13F filing, ranked by portfolio weight.
54 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 ABVX ABIVAX SA AMERICAN DEPOSITARY SHARES | 19.24% | $23.70 | $88.15 | +271.94% | Trimmed -7.30% |
 TNGX TANGO THERAPEUTICS INC | 6.82% | $5.00 | $23.81 | +376.20% | Trimmed -13.77% |
 CGON CG ONCOLOGY INC | 6.27% | $42.46 | $63.82 | +50.31% | Held |
 COGT COGENT BIOSCIENCES INC | 4.52% | $9.47 | $31.00 | +227.35% | Trimmed -1.87% |
 IMVT IMMUNOVANT INC | 4.13% | $25.06 | $30.47 | +21.59% | Held |
 SYRE SPYRE THERAPEUTICS INC | 4.06% | $23.49 | $85.69 | +264.79% | Held |
 DNTH DIANTHUS THERAPEUTICS INC | 3.93% | $23.63 | $82.37 | +248.58% | Held |
 MIRM MIRUM PHARMACEUTICALS INC | 2.99% | $91.60 | $86.01 | -6.10% | Held |
 AMLX AMYLYX PHARMACEUTICALS INC | 2.70% | $3.80 | $28.14 | +640.53% | Held |
 GLUE MONTE ROSA THERAPEUTICS INC | 2.69% | $15.68 | $10.30 | -34.31% | Held |
Showing 1-10 of 54